A 2.5-Year Weight Management Program Using Noom Health: Protocol for a Randomized Controlled Trial.
DPP
Diabetes Prevention Program
Noom
digital health
mobile phone
weight loss
weight loss maintenance
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
12 Aug 2022
12 Aug 2022
Historique:
received:
24
02
2022
accepted:
28
06
2022
revised:
28
06
2022
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
Overweight and obesity are serious public health concerns. As the prevalence of excess weight among individuals continues to increase, there is a parallel need for inexpensive, highly accessible, and evidence-based weight loss programs. This weight loss trial will aim to examine the efficacy of the Noom weight loss program in comparison to a digital control after a 6-month intervention phase and a 24-month maintenance phase, with assessments continuing for 2 years beyond the intervention (to 30 months-after the baseline). The secondary outcomes include quality of life, psychosocial functioning, sleep quality, physical activity, diet, and health status. This trial will also examine the severity of obesity-related functional impairment, weight loss history, and demographic moderators, along with adherence and self-efficacy as mediators of the outcome. A total of 600 participants were randomized in a parallel-group, controlled trial to either Noom Healthy Weight Program (intervention) or Noom Healthy Weight Control (control) for a 6-month intervention. Both intervention and control groups include diet and exercise recommendations, educational content, daily logging capabilities, and daily weigh-in entries. The Noom Healthy Weight Program also includes a coach support for weight loss. Remote follow-up assessments of eating, physical activity, psychosocial factors, app use data, and weight will be conducted at 1, 4, 6, 12, 18, 24, and 30 months after baseline. Weight is measured at each follow-up point during a Zoom call using the participants' scales. Enrollment began in March 2021 and the 6-month intervention phase ended in March 2022. Data collection for the final assessment will be completed in March 2024. This study tests commercially available digital lifestyle interventions for individuals with overweight and obesity seeking weight loss support. Data obtained from the study will evaluate whether the Noom Healthy Weight Control Program can help individuals overcome weight loss, achieve long-term maintenance, adhere to lifestyle changes, and feature use barriers that are present in other traditional weight loss treatments. ClinicalTrials.gov NCT04797169; https://clinicaltrials.gov/ct2/show/NCT04797169. DERR1-10.2196/37541.
Sections du résumé
BACKGROUND
BACKGROUND
Overweight and obesity are serious public health concerns. As the prevalence of excess weight among individuals continues to increase, there is a parallel need for inexpensive, highly accessible, and evidence-based weight loss programs.
OBJECTIVE
OBJECTIVE
This weight loss trial will aim to examine the efficacy of the Noom weight loss program in comparison to a digital control after a 6-month intervention phase and a 24-month maintenance phase, with assessments continuing for 2 years beyond the intervention (to 30 months-after the baseline). The secondary outcomes include quality of life, psychosocial functioning, sleep quality, physical activity, diet, and health status. This trial will also examine the severity of obesity-related functional impairment, weight loss history, and demographic moderators, along with adherence and self-efficacy as mediators of the outcome.
METHODS
METHODS
A total of 600 participants were randomized in a parallel-group, controlled trial to either Noom Healthy Weight Program (intervention) or Noom Healthy Weight Control (control) for a 6-month intervention. Both intervention and control groups include diet and exercise recommendations, educational content, daily logging capabilities, and daily weigh-in entries. The Noom Healthy Weight Program also includes a coach support for weight loss. Remote follow-up assessments of eating, physical activity, psychosocial factors, app use data, and weight will be conducted at 1, 4, 6, 12, 18, 24, and 30 months after baseline. Weight is measured at each follow-up point during a Zoom call using the participants' scales.
RESULTS
RESULTS
Enrollment began in March 2021 and the 6-month intervention phase ended in March 2022. Data collection for the final assessment will be completed in March 2024.
CONCLUSIONS
CONCLUSIONS
This study tests commercially available digital lifestyle interventions for individuals with overweight and obesity seeking weight loss support. Data obtained from the study will evaluate whether the Noom Healthy Weight Control Program can help individuals overcome weight loss, achieve long-term maintenance, adhere to lifestyle changes, and feature use barriers that are present in other traditional weight loss treatments.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT04797169; https://clinicaltrials.gov/ct2/show/NCT04797169.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
DERR1-10.2196/37541.
Identifiants
pubmed: 35969439
pii: v11i8e37541
doi: 10.2196/37541
pmc: PMC9419047
doi:
Banques de données
ClinicalTrials.gov
['NCT04797169']
Types de publication
Journal Article
Langues
eng
Pagination
e37541Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR004419
Pays : United States
Informations de copyright
©Robyn Sysko, Jessica Bibeau, Allison Boyar, Kayla Costello, Andreas Michaelides, Ellen Siobhan Mitchell, Annabel Susanin, Tom Hildebrandt. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 12.08.2022.
Références
Am J Clin Nutr. 2005 Jul;82(1 Suppl):222S-225S
pubmed: 16002825
Adv Nutr. 2011 Jul;2(4):368-9
pubmed: 22332078
Telemed J E Health. 2019 Feb;25(2):85-92
pubmed: 29847222
JMIR Mhealth Uhealth. 2018 May 03;6(5):e93
pubmed: 29724709
Telemed J E Health. 2020 Mar;26(3):365-368
pubmed: 30994410
Behav Sleep Med. 2011 Dec 28;10(1):6-24
pubmed: 22250775
Behav Res Ther. 2021 Jun;141:103850
pubmed: 33839586
Health Psychol Rev. 2020 Mar;14(1):132-144
pubmed: 31957557
Scand J Psychol. 2021 Aug;62(4):574-585
pubmed: 34060091
Behav Res Methods. 2018 Oct;50(5):2125-2143
pubmed: 29247385
J Diabetes Res. 2017;2017:2615681
pubmed: 28890899
Am J Prev Med. 2021 Oct;61(4):606-617
pubmed: 34544560
Psychiatr Clin North Am. 2011 Dec;34(4):717-32
pubmed: 22098799
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Med Internet Res. 2019 Jun 21;21(6):e14265
pubmed: 31228174
Ann Intern Med. 2005 Aug 16;143(4):251-64
pubmed: 16103469
JMIR Mhealth Uhealth. 2016 Jul 26;4(3):e87
pubmed: 27460502
J Health Commun. 2017 May;22(5):395-402
pubmed: 28339324
Digit Health. 2020 Nov 30;6:2055207620976755
pubmed: 33294209
Exp Gerontol. 2022 Aug;165:111837
pubmed: 35598698
J Am Diet Assoc. 2007 Jun;107(6):1002-7
pubmed: 17524721
J Cardiovasc Nurs. 2009 Jan-Feb;24(1):58-80
pubmed: 19114803
Int J Med Inform. 2016 Oct;94:81-90
pubmed: 27573315
JMIR Mhealth Uhealth. 2019 Feb 28;7(2):e12209
pubmed: 30816851
Prev Med. 2016 Nov;92:51-57
pubmed: 27095323
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Obes Rev. 2010 Apr;11(4):306-21
pubmed: 19754633
Lancet Diabetes Endocrinol. 2014 Dec;2(12):954-62
pubmed: 25459211
J Behav Med. 2019 Apr;42(2):365-375
pubmed: 30311111
Assessment. 2009 Mar;16(1):16-30
pubmed: 18703821
Am J Prev Med. 2013 Nov;45(5):576-82
pubmed: 24139770
J Am Diet Assoc. 2011 Jan;111(1):92-102
pubmed: 21185970
Obesity (Silver Spring). 2020 Mar;28(3):521-528
pubmed: 32030910
Diabetes Care. 2002 Dec;25(12):2165-71
pubmed: 12453955
Obes Res. 1995 May;3(3):241-8
pubmed: 7627772
Diabetes Care. 2007 Jun;30(6):1374-83
pubmed: 17363746
Sci Rep. 2016 Nov 07;6:34563
pubmed: 27819345
J Nutr Educ Behav. 2021 Sep;53(9):732-741
pubmed: 34315678
Annu Rev Nutr. 2001;21:323-41
pubmed: 11375440
Multivariate Behav Res. 2013 May;48(3):370-97
pubmed: 26741847
Health Promot Perspect. 2020 Jul 12;10(3):230-237
pubmed: 32802759
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Obesity (Silver Spring). 2007 Dec;15(12):3091-6
pubmed: 18198319
Contemp Clin Trials. 2021 Jan;100:106217
pubmed: 33197609
Prev Med. 2010 Aug;51(2):123-8
pubmed: 20478333
Stat Med. 2013 May 20;32(11):1964-73
pubmed: 23303653
Obesity (Silver Spring). 2014 Jul;22 Suppl 2:S41-410
pubmed: 24227637
Health Psychol. 2000 Jan;19(1S):5-16
pubmed: 10709944
Am J Prev Med. 2018 Nov;55(5):583-591
pubmed: 30262149
Obes Res Clin Pract. 2017 Mar - Apr;11(2):206-214
pubmed: 27292942
Obes Rev. 2005 Feb;6(1):67-85
pubmed: 15655039
Obes Rev. 2016 Sep;17(9):895-906
pubmed: 27192162
Am J Psychiatry. 2016 Jul 1;173(7):672-9
pubmed: 26988629
Ann Intern Med. 2014 Nov 18;161(10 Suppl):S5-12
pubmed: 25402403
Am J Psychiatry. 2020 Feb 1;177(2):134-142
pubmed: 32008396
Struct Equ Modeling. 2008;15(1):23-51
pubmed: 20179778
Nutrients. 2020 Jul 03;12(7):
pubmed: 32635174
JMIR Mhealth Uhealth. 2018 Jun 20;6(6):e145
pubmed: 29925496